Wells Fargo Maintains Overweight on F N B, Lowers Price Target to $21

Benzinga Newsdesk www.benzinga.com Negative 87.2%

Neg 87.2% Neu 0% Pos 0%

Wells Fargo analyst Terry McEvoy maintains F N B (NYSE:FNB) with a Overweight and lowers the price target from $22 to $21.